“genzyme” Archives

Entry Author Date Location
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
For San Antonio’s Consideration: A Biotech Incubator and Accelerator 04/08/16 Texas
At Long Last, First Drug Approval in Sight for Amicus 04/01/16 New York
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
Flint’s Water, Wicab, & New Leaders: This Week’s Wisconsin Watchlist 02/05/16 Wisconsin
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
Boston Tech Scene Gains Big Anchor Tenant in General Electric 01/13/16 Boston
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
In 2015, U-M Tech Transfer Topped Record-Breaking 2014 Numbers 09/22/15 Detroit Ann Arbor
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Aura Bio Gets $21M, Pivots to Rare Eye Cancers With Virus Nanotech 03/05/15 Boston
“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap 03/04/15 San Francisco
Page 1 of 17 next page »